Your browser doesn't support javascript.
loading
Single and combined BTK and PI3Kδ inhibition with acalabrutinib and ACP-319 in pre-clinical models of aggressive lymphomas.
Spriano, Filippo; Tarantelli, Chiara; Gaudio, Eugenio; Gerlach, Magdalena M; Priebe, Valdemar; Cascione, Luciano; Bernasconi, Elena; Targa, Altea; Mascia, Michele; Dirnhofer, Stefan; Stathis, Anastasios; Zucca, Emanuele; Bertoni, Francesco.
Afiliação
  • Spriano F; Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Tarantelli C; Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Gaudio E; Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Gerlach MM; Institute of Pathology and Medical Genetics, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Priebe V; Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Cascione L; Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Bernasconi E; Swiss Institute of Bioinformatics (SIB), Lausanne, Switzerland.
  • Targa A; Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Mascia M; Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Dirnhofer S; Institute of Oncology Research, Università della Svizzera italiana, Bellinzona, Switzerland.
  • Stathis A; Institute of Pathology and Medical Genetics, University Hospital Basel, University of Basel, Basel, Switzerland.
  • Zucca E; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
  • Bertoni F; Oncology Institute of Southern Switzerland, Bellinzona, Switzerland.
Br J Haematol ; 187(5): 595-601, 2019 12.
Article em En | MEDLINE | ID: mdl-31355927
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazinas / Quinolinas / Benzamidas / Protocolos de Quimioterapia Combinada Antineoplásica / Adenosina / Linfoma de Células B Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazinas / Quinolinas / Benzamidas / Protocolos de Quimioterapia Combinada Antineoplásica / Adenosina / Linfoma de Células B Limite: Animals / Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article